Sumatriptan is a selective agonist at 5HT\textsubscript{1B/1D} receptors, used primarily in the treatment of acute migraine attacks. Activation of these receptors leads to vasoconstriction of cranial blood vessels and inhibition of pro-inflammatory neuropeptide release.